Zuvius Lifesciences headquartered in Mumbai, India, is a global healthcare company specializing in chemotherapeutic formulations. Dedicated towards redefining quality of life, our products span the breadth of cancer care. Enriched with a portfolio of leading science-based offerings in oncology care and nutraceuticals, we have delivered values in the lives of people for more than 20 years.
Zuvius is an integrated research-based organization, renowned for its quality and commitment. Built with a vision of making affordable cancer care accessible across the globe, the company has curated a range of 200+ high-quality anti-cancer medicines that reach out to patients. Backed by some of the finest talents of the pharmaceutical industry, Zuvius stands strong in building a legacy of delivering innovative solutions and therapies that would change the perception of cancer.
The word ‘Zuvius’ inspires a ring of positivity, joy and optimism. Zuvius Lifesciences was incepted with the vision of spreading good health across the globe and thereby emerging out as one of the most respected pharmaceutical brands in the industry, specializing in super specialty medicines.
Zuvius Lifesciences is much more than a company, more than simply a manufacturer of super speciality products. We are an eclectic and an ever-expanding mix of people with perspectives and skills to collectively work under the shared responsibility towards our consumers, partners, colleagues and most importantly, towards each other.
Zuvius is an integrated research-based organization, renowned for its quality and commitment. Built with a vision of making affordable cancer care accessible across the globe, the company has curated a range of 200+ high-quality anti-cancer medicines that reach out to patients. Backed by some of the finest talents of the pharmaceutical industry, Zuvius stands strong in building a legacy of delivering innovative solutions and therapies that would change the perception of cancer.
The word ‘Zuvius’ inspires a ring of positivity, joy and optimism. Zuvius Lifesciences was incepted with the vision of spreading good health across the globe and thereby emerging out as one of the most respected pharmaceutical brands in the industry, specializing in super specialty medicines.
Zuvius Lifesciences is much more than a company, more than simply a manufacturer of super speciality products. We are an eclectic and an ever-expanding mix of people with perspectives and skills to collectively work under the shared responsibility towards our consumers, partners, colleagues and most importantly, towards each other.
“Taking the world from ‘Know Cancer to No Cancer”
Zuvius exhales a promise of hope that one day the world will be cancer-free. And we believe, we have a big role to play in turning that dream into a reality. We have built this organization brick by brick on one single foundation – to help people fight cancer with access to quality medicines. Perhaps, access to timely diagnosis and quality medicines is all that’s needed to save a million lives each year!!!
Even today, less than 30% of low-income countries have access to cancer treatment services. And only 14% of cancer patients have access to palliative care. We want to change these dynamics; cancer treatment should be accessible and available to all.
In over a decade’s time, we have earned a specialization in chemotherapeutic formulations. Today, we manufacture the widest range of anti-cancer drugs in the country. Keeping up the pace, we are venturing into supportive therapy and nutraceuticals, which too plays a crucial role in bringing solace and comfort to cancer patients.
In this honest quest of eradicating cancer, each person associated with us, the partners, employees, stakeholders, and investors have made an enduring contribution that shall never be forgotten. They have shared our vision of a cancer-free world, trusted us with our potential, guided us along the way, and most importantly stood by us through the highs and lows of this ride.
In over a decade’s time, we have earned a specialization in chemotherapeutic formulations. Today, we manufacture the widest range of anti-cancer drugs in the country. Keeping up the pace, we are venturing into supportive therapy and nutraceuticals, which too plays a crucial role in bringing solace and comfort to cancer patients.
In this honest quest of eradicating cancer, each person associated with us, the partners, employees, stakeholders, and investors have made an enduring contribution that shall never be forgotten. They have shared our vision of a cancer-free world, trusted us with our potential, guided us along the way, and most importantly stood by us through the highs and lows of this ride.
(Chairman & Managing Director)
Zuvius Lifesciences was founded in 2005, by the Directors – Mr. Nimish Thakkar, Mrs. Alka Chavan and Mr. Shailesh Shetty, with the simple and profound belief of keeping people above profit and quality above quantity. Dr. Ulhas Ganu, a renowned professional with over 30 years of experience in the field of oncology research and medical marketing, joined the team as a technical director. His rich experience brings deep scientific credibility to Zuvius Lifesciences.
Steering towards a world where cancer is just another disease, treatable and curable!Redefining Health, Rediscovering Life
To become a global leader in creating a holistic portfolio of quality cancer care that encompasses every aspect from early diagnosis to treatment to palliative care!
Zuvius respects the dignity of each patient. It’s their quality of life with cancer and post-cancer that matters the most to us. That’s why everything we do imbibes the values of honesty, integrity, quality, commitment, and transparency.
With a paltry initial capital, a 19-year-old lad started a medical distribution company in 1995 named Nimish Medical Services that catered to generic medicines covering the central suburbs of Mumbai.
Slowly and steadily, Nimish Medical Services bloomed. It ventured into newer segments – Immunology, Cardiology, Gynecology, Neurology, Nephrology and finally – Oncology
By 2004, the firm earned monopoly in distributing high-end medicines of this niche segment. By this time, the company added two more jewels, Mrs. Alka Chavan and Mr. Shailesh Shetty.
Life was good and business flourishing. But the team felt the quiver of a bigger calling! They stepped up to set a pharmaceutical company of their own and that marked the birth of ‘Zuvius Life Sciences’.
Zuvius was built on the foundation of ‘quality care for cancer patients’. We started with a single product and in less than a year, we sprawled across Pan India with a full-fledged team of 28 employees. With great growth came greater responsibilities.
Zuvius faced a huge crisis that led to crippling loss amounting to crores. A major delay in delivery led to hefty salaries and huge expenses. When stocks arrived, the sales fizzed. The dead stocks lied unsold at various points across the country. With heavy pay outs and zero inflows, Zuvius started to sink.
We still remember the date, 30th March 2008. Our heart sank as we pulled the shutters down, thinking it was the end we never saw coming. But with a dim gleam of hope, the three of us gathered the grit for one last shot! We called back all the dead stocks from different points and sent out post-dated cheques as refund. Our only hope at that point was to recover the money by selling off the stock.
Our credibility in the industry helped us in picking the pieces. Nimish handled the sales in West India and Alka took over the East. Sailesh stayed back to uphold the pillar once again. It was a harrowing but fulfilling experience. Nimish and Alka allied with distributors from different zones and soon they had the cash flowing in. At the bottom of the abyss, they found a new beginning. The hard work and integrity displayed by the team earned them respect and trust within the industry circle. Zuvius also tucked another feather in the cap with notable research scientist Dr. Ulhas Ganu becoming a part of the core team. In due time, Zuvius became the most respected brand of oncology medication in India.
Once, the company strengthened its foothold in the industry there was no looking back. They increased the product range, launched several new molecules for the first time, and continued rigorous research on cancer treatment. By 2015, they had built a portfolio of 70+ anti-cancer drugs. And their dream of building global access to cancer care started to take form. Zuvius registered its products in many countries covering Africa, Latin America, CIS, and South-East Asia. Today, Zuvius is actively invested in research and development of life-saving drugs against cancer. It is making new strides in supportive therapies and nutraceuticals that adds value to the quality of life. And above all, Zuvius is embracing its dream by spanning across borders reaching out to people in need.
The company was expecting a steep growth in coming years, when the world was hit by Covid. Everything came to stand still. Moving around was difficult, from manufacturing to transportation to delivery. But the passion didn’t die. The call for requirement of medicines from hospitals and doctors could be heard loud and clear.
The cancer patients were suffering as many hospitals were turned into covid centers. The patients were in deep stress and were looking for the treatment to be continued. In this challenging time, we ensured that production continues with minimum number of labourers, and we managed to provide supplies. The entire team at Zuvius was dedicated, be it production, sales or back office. They silently fulfilled their duties and served the Cancer patients dedicatedly. The team didn’t give up. We worked together, we cared for each other. Essential members travelled to office, while others worked from home. The sales team were in touch with their clients throughout. Our silent fighters fought the covid times and fought very hard. We demonstrated a great team effort and togetherness. We moved on and sustained.The government indeed help to ensure that medical supplies does not stop.
This was the time when the market opened and welcomed with open arms. The requirement for anticancer medicines within and outside the nation grew in length and breadth. Simultaneously, with our continuous improvement we launched more products thereby taking our product basket to over 200 products in oncology domain. With the weapon of widest range of anticancer medicines, and consistent quality products, Zuvius leaped to different parts of the world. Capitalizing on such huge opportunity, we connected ourselves to African, Asian, and LatAm countries. With EU GMP certification, we started our journey in regulated European markets as well. We are now exporting to 32 countries.
Back to where it all began
With a paltry initial capital, a 19-year-old lad started a medical distribution company in 1995 named Nimish Medical Services that catered to generic medicines covering the central suburbs of Mumbai.
Growing branch by branch
Slowly and steadily, Nimish Medical Services bloomed. It ventured into newer segments – Immunology, Cardiology, Gynecology, Neurology, Nephrology and finally – Oncology.
Monopoly is the game
By 2004, the firm earned monopoly in distributing high-end medicines of this niche segment. By this time, the company added two more jewels, Mrs. Alka Chavan and Mr. Shailesh Shetty.
The bigger calling
Life was good and business flourishing. But the team felt the quiver of a bigger calling! They stepped up to set a pharmaceutical company of their own and that marked the birth of ‘Zuvius Life Sciences’.
To new beginnings
Zuvius was built on the foundation of ‘quality care for cancer patients’. We started with a single product and in less than a year, we sprawled across Pan India with a full-fledged team of 28 employees. With great growth came greater responsibilities.
Hitting rock bottom
Zuvius faced a huge crisis that led to crippling loss amounting to crores. A major delay in delivery led to hefty salaries and huge expenses. When stocks arrived, the sales fizzed. The dead stocks lied unsold at various points across the country. With heavy pay outs and zero inflows, Zuvius started to sink.
Falling further apart
We still remember the date, 30th March 2008. Our heart sank as we pulled the shutters down, thinking it was the end we never saw coming. But with a dim gleam of hope, the three of us gathered the grit for one last shot!
We called back all the dead stocks from different points and sent out post-dated cheques as refund. Our only hope at that point was to recover the money by selling off the stock.
Resurrecting from the ashes
Our credibility in the industry helped us in picking the pieces. Nimish handled the sales in West India and Alka took over the East. Sailesh stayed back to uphold the pillar once again.
It was a harrowing but fulfilling experience. Nimish and Alka allied with distributors from different zones and soon they had the cash flowing in. At the bottom of the abyss, they found a new beginning.
The hard work and integrity displayed by the team earned them respect and trust within the industry circle. Zuvius also tucked another feather in the cap with notable research scientist Dr. Ulhas Ganu becoming a part of the core team. In due time, Zuvius became the most respected brand of oncology medication in India.
Growing out and abound
Once, the company strengthened its foothold in the industry there was no looking back. They increased the product range, launched several new molecules for the first time, and continued rigorous research on cancer treatment.
By 2015, they had built a portfolio of 70+ anti-cancer drugs. And their dream of building global access to cancer care started to take form. Zuvius registered its products in many countries covering Africa, Latin America, CIS, and South-East Asia.
Today, Zuvius is actively invested in research and development of life-saving drugs against cancer. It is making new strides in supportive therapies and nutraceuticals that adds value to the quality of life. And above all, Zuvius is embracing its dream by spanning across borders reaching out to people in need.
Covid Times
The company was expecting a steep growth in coming years, when the world was hit by Covid. Everything came to stand still. Moving around was difficult, from manufacturing to transportation to delivery. But the passion didn’t die. The call for requirement of medicines from hospitals and doctors could be heard loud and clear.
The cancer patients were suffering as many hospitals were turned into covid centers. The patients were in deep stress and were looking for the treatment to be continued. In this challenging time, we ensured that production continues with minimum number of labourers, and we managed to provide supplies. The entire team at Zuvius was dedicated, be it production, sales or back office. They silently fulfilled their duties and served the Cancer patients dedicatedly.
The team didn’t give up. We worked together, we cared for each other. Essential members travelled to office, while others worked from home. The sales team were in touch with their clients throughout. Our silent fighters fought the covid times and fought very hard. We demonstrated a great team effort and togetherness. We moved on and sustained.The government indeed help to ensure that medical supplies does not stop.
This was the time when the market opened and welcomed with open arms. The requirement for anticancer medicines within and outside the nation grew in length and breadth. Simultaneously, with our continuous improvement we launched more products thereby taking our product basket to over 200 products in oncology domain. With the weapon of widest range of anticancer medicines, and consistent quality products, Zuvius leaped to different parts of the world. Capitalizing on such huge opportunity, we connected ourselves to African, Asian, and LatAm countries. With EU GMP certification, we started our journey in regulated European markets as well. We are now exporting to 32 countries.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.